Lv4
448 积分 2022-04-25 加入
First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of DS‐7011a, an Anti‐TLR7 Antagonistic Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
1天前
已完结
Drug developers switch gears to inhibit STING
8天前
已完结
Small-molecule inhibition of TLR8 through stabilization of its resting state
8天前
已完结
Expression of Cyclic GMP‐AMP Synthase in Patients With Systemic Lupus Erythematosus
11天前
已完结
Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases
12天前
已完结
Inhibition of Cyclic GMP‐AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1‐Deficient Mice
13天前
已完结
GPCR drug discovery: new agents, targets and indications
14天前
已完结
Volume of Distribution in Drug Design
14天前
已完结
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
15天前
已完结
PROTAC targeted protein degraders: the past is prologue
19天前
已完结
皖公网安备34019202002308
